Tag | Symbol | sector | industry | Interval | % |
---|---|---|---|---|---|
nervous system | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
antiviral | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
hepatitis | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
renal | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
kidney diseases | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
autonomous | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
kidney | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
treatment | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
clinical trials | RGLS | Health Technology | Pharmaceuticals: Other | 1y | 61.7884983085748 |
Tag | Interval | Occurency | Average % | Max % |
---|---|---|---|---|
antiviral | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
autonomous | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
clinical trials | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
hepatitis | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
kidney | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
kidney diseases | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
nervous system | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
renal | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
treatment | 1y | 1 | 61.7884983085748 | 61.7884983085748 |
Sector | Interval | Occurency | Average % | Max % |
---|---|---|---|---|
Health Technology | 1y | 9 | 61.7884983085748 | 61.7884983085748 |
Industry | Interval | Occurency | Average % | Max % |
---|---|---|---|---|
Pharmaceuticals: Other | 1y | 9 | 61.7884983085748 | 61.7884983085748 |